← Back to All US Stocks

DCGO Stock Analysis - DocGo Inc. AI Rating

DCGO Nasdaq Services-Health Services DE CIK: 0001822359
Recently Updated • Analysis: Mar 23, 2026 • SEC Data: 2025-12-31
STRONG SELL
92%
Pending
Analysis scheduled

📊 DCGO Key Takeaways

Revenue: $322.2M
Net Margin: -56.6%
Free Cash Flow: $29.9M
Current Ratio: 2.26x
Debt/Equity: 0.00x
EPS: $-1.84
AI Rating: STRONG SELL with 92% confidence

Investment Thesis

Claude

DocGo is in severe financial distress with collapsing revenue (-47.7% YoY), massive operating losses (-178M), and a negative net margin of -56.6%. Despite positive operating cash flow of 34.5M, the company's fundamental profitability metrics and deteriorating revenue base suggest structural business challenges that cannot be overlooked. The significant operating losses and negative returns on equity/assets indicate the company is destroying shareholder value at an alarming rate.

DCGO Strengths

Claude
  • + Positive operating cash flow of 34.5M provides near-term liquidity
  • + Adequate cash position of 51M with minimal debt (235.6K)
  • + Strong current ratio of 2.26x indicates short-term solvency

DCGO Risks

Claude
  • ! Severe revenue contraction of -47.7% YoY signals loss of market share or demand collapse
  • ! Operating losses of -178M with negative operating margin of -55.3% indicate unsustainable core operations
  • ! Negative ROE of -126.7% and ROA of -84.0% demonstrate systematic capital destruction
  • ! Negative interest coverage of -1615.5x shows inability to service debt from operations
  • ! Zero Form 4 insider filings suggest lack of insider confidence

Key Metrics to Watch

Claude
  • * Quarterly revenue trends and stabilization signals
  • * Path to operating profitability and timeline to positive operating margin
  • * Operating cash flow sustainability and burn rate relative to cash reserves
  • * Gross margin and pricing power recovery

DCGO Financial Metrics

Revenue
$322.2M
Net Income
$-182.4M
EPS (Diluted)
$-1.84
Free Cash Flow
$29.9M
Total Assets
$217.1M
Cash Position
$51.0M

💡 AI Analyst Insight

Strong liquidity with a 2.26x current ratio provides a solid financial cushion.

DCGO Profitability Ratios

Gross Margin N/A
Operating Margin -55.3%
Net Margin -56.6%
ROE -126.7%
ROA -84.0%
FCF Margin 9.3%

DCGO vs Default Sector

How DocGo Inc. compares to Default sector averages

Net Margin
DCGO -56.6%
vs
Sector Avg 12.0%
DCGO Sector
ROE
DCGO -126.7%
vs
Sector Avg 15.0%
DCGO Sector
Current Ratio
DCGO 2.3x
vs
Sector Avg 1.8x
DCGO Sector
Debt/Equity
DCGO 0.0x
vs
Sector Avg 0.7x
DCGO Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

DCGO Balance Sheet & Liquidity

Current Ratio
2.26x
Quick Ratio
2.26x
Debt/Equity
0.00x
Debt/Assets
42.0%
Interest Coverage
-1,615.51x
Long-term Debt
$235.6K

DCGO 5-Year Financial Trend

DCGO 5-year financial data: Year 2021: Revenue $318.7M, Net Income -$14.8M, EPS $-0.25. Year 2022: Revenue $440.5M, Net Income $23.7M, EPS $0.25. Year 2023: Revenue $624.3M, Net Income N/A, EPS $0.25. Year 2024: Revenue $624.3M, Net Income N/A, EPS $0.34. Year 2025: Revenue $624.3M, Net Income $6.9M, EPS $0.06.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: DocGo Inc.'s revenue has grown significantly by 96% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.06 reflects profitable operations.

DCGO Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
9.3%
Free cash flow / Revenue

DCGO Quarterly Performance

Quarterly financial performance data for DocGo Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $70.8M $5.5M $0.05
Q2 2025 $80.4M $6.5M $0.06
Q1 2025 $96.0M N/A $-0.09
Q3 2024 $138.7M N/A $-0.01
Q2 2024 $125.5M N/A $-0.02
Q1 2024 $113.0M N/A $-0.03
Q3 2023 $104.3M N/A $-0.01
Q2 2023 $109.5M N/A $-0.02

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

DCGO Capital Allocation

Operating Cash Flow
$34.5M
Cash generated from operations
Stock Buybacks
$10.8M
Shares repurchased (TTM)
Capital Expenditures
$4.5M
Investment in assets
Dividends
None
No dividend program

DCGO SEC Filings

Access official SEC EDGAR filings for DocGo Inc. (CIK: 0001822359)

📋 Recent SEC Filings

Date Form Document Action
Mar 16, 2026 10-K dcgo-20251231.htm View →
Mar 16, 2026 8-K dcgo-20260316.htm View →
Jan 30, 2026 8-K dcgo-20260126.htm View →
Dec 16, 2025 4 xslF345X05/wk-form4_1765924942.xml View →
Dec 16, 2025 4 xslF345X05/wk-form4_1765919806.xml View →

Frequently Asked Questions about DCGO

What is the AI rating for DCGO?

DocGo Inc. (DCGO) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are DCGO's key strengths?

Claude: Positive operating cash flow of 34.5M provides near-term liquidity. Adequate cash position of 51M with minimal debt (235.6K).

What are the risks of investing in DCGO?

Claude: Severe revenue contraction of -47.7% YoY signals loss of market share or demand collapse. Operating losses of -178M with negative operating margin of -55.3% indicate unsustainable core operations.

What is DCGO's revenue and growth?

DocGo Inc. reported revenue of $322.2M.

Does DCGO pay dividends?

DocGo Inc. does not currently pay dividends.

Where can I find DCGO SEC filings?

Official SEC filings for DocGo Inc. (CIK: 0001822359) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is DCGO's EPS?

DocGo Inc. has a diluted EPS of $-1.84.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 23, 2026 | Data as of: 2025-12-31 | Powered by Claude AI